World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
51
Citations
15095
World Ranking
4112
National Ranking
1873

Shu-Hsia Chen publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Shu-Hsia Chen sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 169 publications — 23rd percentile

23% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Shu-Hsia Chen D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Shu-Hsia Chen sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 51 D-Index — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Shu-Hsia Chen is affiliated with the Icahn School of Medicine at Mount Sinai in the United States. Their research primarily spans the fields of Medicine, Biochemistry, Genetics and Molecular Biology, and Immunology and Microbiology, with a focus on oncology and immunology.

The scientist's work includes significant contributions to the following main topics:

  • Cancer Immunotherapy and Biomarkers
  • Immune cells in cancer
  • Cancer Cells and Metastasis
  • Immunotherapy and Immune Responses
  • CAR-T cell therapy research
  • Immune Cell Function and Interaction
  • Cancer Research and Treatments

In terms of subfields, their publications concentrate on:

  • Oncology
  • Immunology
  • Molecular Biology
  • Cancer Research
  • Genetics

Chen's research has been published frequently in several venues, including:

  • Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Frontiers in Immunology
  • Advanced Science
  • Cancer Research Communications

Some of their recent papers include:

  • "Neutralizing Aptamers Block S/RBD-ACE2 Interactions and Prevent Host Cell Infection," 2021, Angewandte Chemie International Edition
  • "A phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancer," 2021, Science Translational Medicine
  • "Potentiating Antitumor Efficacy Through Radiation and Sustained Intratumoral Delivery of Anti-CD40 and Anti-PDL1," 2020, International Journal of Radiation Oncology*Biology*Physics
  • "Mathematical prediction of clinical outcomes in advanced cancer patients treated with checkpoint inhibitor immunotherapy," 2020, Science Advances
  • "Osteoprogenitor-GMP crosstalk underpins solid tumor-induced systemic immunosuppression and persists after tumor removal," 2023, Cell Stem Cell

Their collaborations involve frequent co-authorship with several researchers, including:

  • Yitian Xu
  • Ping-Ying Pan
  • Licheng Zhang
  • Junjun Zheng
  • Nourhan Abdelfattah

Best Publications

  • Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

    Vincenzo Bronte;Sven Brandau;Shu Hsia Chen;Mario P. Colombo

  • Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host

    Bo Huang;Ping Ying Pan;Qingsheng Li;Alice I. Sato

  • The terminology issue for myeloid-derived suppressor cells.

    Dmitry I. Gabrilovich;Vincenzo Bronte;Shu Hsia Chen;Mario P. Colombo

  • The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies.

    Junko Ozao-Choy;Ge Ma;Johnny Kao;George X. Wang

  • Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer.

    Ping Ying Pan;Ge Ma;Kaare J. Weber;Junko Ozao-Choy

  • Gr-1+ Myeloid Cells Derived from Tumor-Bearing Mice Inhibit Primary T Cell Activation Induced Through CD3/CD28 Costimulation

    Sergei A. Kusmartsev;Yu Li;Shu-Hsia Chen

  • Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function

    Ping Ying Pan;George X. Wang;Bingjiao Yin;Junko Ozao

  • Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice.

    Catherine Martel;Wenjun Li;Brian Fulp;Andrew M. Platt

  • Interleukin 10 suppresses Th17 cytokines secreted by macrophages and T cells

    Yongpeng Gu;Jianfei Yang;Xinshou Ouyang;Weicheng Liu

  • Inhibitory receptors bind ANGPTLs and support blood stem cells and leukaemia development

    Junke Zheng;Junke Zheng;Masato Umikawa;Masato Umikawa;Changhao Cui;Jiyuan Li

  • Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model.

    Bert W. O'Malley;Shu Hsia Chen;Mary R. Schwartz;Savio L C Woo

  • Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity

    Hui-Ming Chen;William van der Touw;Yuan Shuo Wang;Kyeongah Kang

  • Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice

    Mercedes Rodriguez Garcia;Levi Ledgerwood;Yu Yang;Jiangnan Xu

  • Paired immunoglobin-like receptor-B regulates the suppressive function and fate of myeloid-derived suppressor cells

    Ge Ma;Ping Ying Pan;Samuel Eisenstein;Celia M. Divino

  • Myeloid-Derived Suppressor Cells Prevent Type 1 Diabetes in Murine Models

    Bingjiao Yin;Ge Ma;Chun Yu Yen;Chun Yu Yen;Zuping Zhou

  • DC-SIGN(+) Macrophages Control the Induction of Transplantation Tolerance.

    Patricia Conde;Mercedes Rodriguez;William van der Touw;Ana Jimenez

  • Development and function of myeloid-derived suppressor cells generated from mouse embryonic and hematopoietic stem cells.

    Zuping Zhou;Deborah L. French;G. E. Ma;Samuel Eisenstein

  • Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor release.

    Padmini Jayaraman;Falguni Parikh;Esther Lopez-Rivera;Yared Hailemichael

  • Targeting immune suppressing myeloid-derived suppressor cells in oncology

    Johnny Kao;Eric C. Ko;Samuel Eisenstein;Andrew G. Sikora

  • Adenovirus‐mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy leads to systemic activity against spontaneous and induced metastasis in an orthotopic mouse model of prostate cancer

    Simon J. Hall;Steven E. Mutchnik;Shu Hsia Chen;Savio L C Woo

  • Combination Gene Therapy for Oral Cancer in a Murine Model

    Bert W. O'Malley;Keary A. Cope;Shu Hsia Chen;Daqing Li

  • Role of immature myeloid Gr-1+ cells in the development of antitumor immunity.

    Qingsheng Li;Ping-Ying Pan;Peidi Gu;Dongping Xu

  • Immunomodulatory gene therapy with interleukin 12 and 4-1BB ligand: Long-term remission of liver metastases in a mouse model

    Olivier Martinet;Vanadyia Ermekova;Jian Q. Qiao;Bernhard Sauter

Frequent Co-Authors

Savio L. C. Woo
Savio L. C. Woo Icahn School of Medicine at Mount Sinai
Myron Schwartz
Myron Schwartz Icahn School of Medicine at Mount Sinai
Swan N. Thung
Swan N. Thung Icahn School of Medicine at Mount Sinai
Jordi Ochando
Jordi Ochando Icahn School of Medicine at Mount Sinai
Gwendalyn J. Randolph
Gwendalyn J. Randolph Washington University in St. Louis
Richard G. Stock
Richard G. Stock Icahn School of Medicine at Mount Sinai
Jonathan S. Bromberg
Jonathan S. Bromberg University of Maryland, Baltimore
Ming-Ming Zhou
Ming-Ming Zhou Icahn School of Medicine at Mount Sinai
Huabao Xiong
Huabao Xiong Icahn School of Medicine at Mount Sinai
Miriam Merad
Miriam Merad Icahn School of Medicine at Mount Sinai

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related healthcare degrees can expand career opportunities. Many students begin with foundational nursing programs. For example, options like easiest absn programs to get into provide an accelerated path to becoming a registered nurse, which is essential for clinical experience in immunology-related fields.

A Licensed Practical Nurse (LPN) qualification is another viable entry point. Accredited and accessible options such as accredited lpn programs easy to get into can help students quickly gain hands-on experience in patient care settings that often intersect with immunological work.

Advancing in nursing can lead to specialized roles. Choosing the right program, like which nurse practitioner program is easiest, allows students to become nurse practitioners who often collaborate closely with immunologists and clinicians.

For those interested in mental health, pathways like best psychiatric mental health nurse practitioner programs online offer specialized training and excellent clinical placements, blending immunology with psychiatric care to address complex patient needs.

Best Scientists Citing Shu-Hsia Chen

Trending Scientists

Recently Published Articles